Paul Suthapong is a serial technology entrepreneur with more than 16 years of experience in human engagement innovations with expertise in digital retails innovation, digital interactive system, and cutting-edge digital marketing. Currently Paul is a CTO and co-founder of Primo, a startup implementing a platform for mobile-based cross-promotional marketing. Previously, Paul founded SpotOn International Group, a set of companies implementing innovative solutions for on-location audience engagements in retail spaces. Paul graduated MBA Entrepreneurship and Innovation from Massachusetts Institute of Technology – Sloan School of Management. He has previously worked as a lead engineer at Microsoft Corporation in Redmond, WA for more than 6 years. Currently Paul is also a core committee member of Thailand Technology Startup Association and Thailand’s biggest angel group: Bangkok Venture Club. Paul is also a startup educator recently curated the national online startup courses for Thailand and is actively teaching startup, entrepreneurship, and innovation subjects at Chulalongkorn Business School and other large corporations.
Did you know?

Miranda Wang and Jeanny Yao have an uncanny talent for finding value where others see waste. Their plastics upcycling company, Novoloop, just raised an $21m Series A to prove it.

To find the future of food, you may have to look no further than Emeryville, CA, a small city by the San Francisco Bay, where Upside Foods has built a 53,000-square-foot production facility for cultivated meat, the first of its kind.

In a timeless dilemma for new parents, Radhika and her husband Bharath discovered early that their baby daughter was a fussy sleeper. The situation left them tired and frustrated; being effective at work became a challenge.

The question for Sumit Sinha and Mukesh Bansal in February 2019 was which would come first: The funding for their seed round or the sale of their Hyundai hatchbacks.

In December 2021 Prellis raised a $14.5 million Series B and has signed partnerships with pharmaceutical behemoths including Bristol Myers Squibb and Sanofi.

It was 2016, and Chiu Chau was on the ropes. He had pitched nearly 150 venture capital firms. No one would invest. Everyone doubted the startup with the open-source laboratory robot.

Tesh Mbaabu rarely showed up to his freshman computer science class at the University of Nairobi. His classmate Mesongo Sibuti noticed.

Adebayo (“Ade”) Alonge and Amy Kao, co-founders of RxAll had nvented a handheld scanner for detecting counterfeit prescription drugs—an illicit, multibillion-dollar industry that kills an estimated 1 million people annually globally and 100,000 in Africa.